Medical technologies can save lives, improve health and contribute to sustainable healthcare. Through innovative devices and diagnostics, the industry delivers value to patients, healthcare professionals, and healthcare systems and society. Technology has been placed at the disposal of the healthcare community to utilise various potent tools to improve patient care.
As we continue in our approach to building the first precision medicine platform in Asia, we seek out strategic equity investments in medical technology companies that can help us achieve our goals.
Our existing key investments
- Biolidics Limited (Biolidics), an associate which owns one of the world’s first fully automated circulating tumor cell enrichment technology
- Clearbridge Biophotonics (CBBP), a subsidiary in computational microscopy
- Singapore Institute of Advance Medicine Holdings (SIAMH), building the first proton therapy centre in Singapore